Phase-1 Study of Folinic Acid to Modulate MGMT Gene in Glioblastoma
Condition(s):Grade IV Astrocytoma; GlioblastomaLast Updated:February 21, 2023Terminated
Hide Studies Not Open or Pending
Condition(s):Grade IV Astrocytoma; GlioblastomaLast Updated:February 21, 2023Terminated
Condition(s):CancerLast Updated:January 15, 2019Completed
Condition(s):Glioblastoma; Glioblastoma Multiforme; Glioma; Astrocytoma; Brain TumorLast Updated:November 22, 2021Completed
Condition(s):Glioblastoma; Malignant GliomaLast Updated:December 12, 2023Completed
Condition(s):Central Nervous System TumorLast Updated:October 19, 2020Completed
Condition(s):Glioblastoma Multiforme; Glioblastoma; Glioblastoma, AdultLast Updated:October 30, 2020Completed
Condition(s):Small Cell Lung CarcinomaLast Updated:August 2, 2021Completed
Condition(s):Central Nervous SystemLast Updated:April 26, 2023Recruiting
Condition(s):Parkinson DiseaseLast Updated:January 11, 2023Completed
Condition(s):Acute Myeloid Leukemia; Lymphoblastic Leukemia; Acute Leukemia; Non Hodgkins Lymphoma; Chronic Myeloid LeukemiaLast Updated:June 14, 2021Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.